Tocqueville Asset Management L.P. increased its stake in Colgate-Palmolive (NYSE:CL) by 25.2% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 810,266 shares of the company’s stock after acquiring an additional 162,960 shares during the period. Tocqueville Asset Management L.P. owned approximately 0.09% of Colgate-Palmolive worth $61,135,000 at the end of the most recent reporting period.
Several other hedge funds and other institutional investors also recently made changes to their positions in CL. Vanguard Group Inc. increased its position in shares of Colgate-Palmolive by 2.4% during the second quarter. Vanguard Group Inc. now owns 67,875,384 shares of the company’s stock worth $5,031,602,000 after purchasing an additional 1,621,392 shares in the last quarter. BlackRock Inc. boosted its holdings in Colgate-Palmolive by 1.4% in the 4th quarter. BlackRock Inc. now owns 52,360,691 shares of the company’s stock valued at $3,950,614,000 after purchasing an additional 711,972 shares in the last quarter. Renaissance Technologies LLC boosted its holdings in Colgate-Palmolive by 42.4% in the 2nd quarter. Renaissance Technologies LLC now owns 9,753,400 shares of the company’s stock valued at $723,020,000 after purchasing an additional 2,903,800 shares in the last quarter. Geode Capital Management LLC boosted its holdings in Colgate-Palmolive by 2.1% in the 4th quarter. Geode Capital Management LLC now owns 8,975,479 shares of the company’s stock valued at $675,751,000 after purchasing an additional 188,455 shares in the last quarter. Finally, Arrowstreet Capital Limited Partnership boosted its holdings in Colgate-Palmolive by 25.3% in the 2nd quarter. Arrowstreet Capital Limited Partnership now owns 6,854,323 shares of the company’s stock valued at $508,111,000 after purchasing an additional 1,385,946 shares in the last quarter. Institutional investors and hedge funds own 73.87% of the company’s stock.
Shares of Colgate-Palmolive (CL) traded down $0.88 during trading hours on Wednesday, hitting $69.99. 4,160,752 shares of the company’s stock traded hands, compared to its average volume of 4,048,186. The company has a quick ratio of 1.00, a current ratio of 1.36 and a debt-to-equity ratio of 27.02. The firm has a market capitalization of $61,260.00, a price-to-earnings ratio of 27.02, a P/E/G ratio of 2.63 and a beta of 0.79. Colgate-Palmolive has a 12 month low of $68.19 and a 12 month high of $77.91.
The firm also recently announced a quarterly dividend, which will be paid on Tuesday, May 15th. Investors of record on Friday, April 20th will be issued a dividend of $0.42 per share. This represents a $1.68 dividend on an annualized basis and a yield of 2.40%. This is a boost from Colgate-Palmolive’s previous quarterly dividend of $0.40. The ex-dividend date of this dividend is Thursday, April 19th. Colgate-Palmolive’s dividend payout ratio (DPR) is presently 61.78%.
In other Colgate-Palmolive news, insider Jennifer Daniels sold 902 shares of the stock in a transaction that occurred on Tuesday, January 9th. The shares were sold at an average price of $75.82, for a total value of $68,389.64. Following the completion of the sale, the insider now owns 37,788 shares in the company, valued at approximately $2,865,086.16. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, VP Henning I. Jakobsen sold 36,215 shares of the stock in a transaction that occurred on Monday, February 5th. The stock was sold at an average price of $71.22, for a total transaction of $2,579,232.30. Following the completion of the sale, the vice president now owns 70,783 shares of the company’s stock, valued at approximately $5,041,165.26. The disclosure for this sale can be found here. Insiders have sold 455,707 shares of company stock valued at $32,443,427 over the last 90 days. 1.02% of the stock is currently owned by insiders.
A number of research firms have recently issued reports on CL. Citigroup lifted their price target on shares of Colgate-Palmolive from $75.00 to $80.00 and gave the company a “neutral” rating in a research report on Tuesday, January 30th. BNP Paribas downgraded Colgate-Palmolive from an “outperform” rating to an “underperform” rating in a research report on Tuesday, January 30th. Jefferies Group restated a “hold” rating and set a $79.00 price objective on shares of Colgate-Palmolive in a research report on Friday, January 26th. Zacks Investment Research upgraded Colgate-Palmolive from a “hold” rating to a “buy” rating and set a $83.00 price target for the company in a report on Tuesday, January 16th. Finally, Macquarie raised shares of Colgate-Palmolive from a “neutral” rating to an “outperform” rating and set a $81.00 price objective for the company in a research note on Tuesday, December 19th. Three investment analysts have rated the stock with a sell rating, ten have issued a hold rating and five have given a buy rating to the stock. Colgate-Palmolive currently has an average rating of “Hold” and a consensus price target of $77.91.
Colgate-Palmolive Company (Colgate) is a consumer products company. The Company operates in two product segments: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through five geographic segments, which include North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.